Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination among adults with immunocompromising conditions.
E. Satué-Gracia (tarragona, Spain), c. de diego cabanes (tarragona, Spain), A. Vila-Rovira (Barcelona, Spain), C. Rodríguez-Casado (Barcelona, Spain), O. Ochoa-Gondar (Tarragona, Spain), A. Vila-Córcoles (Tarragona, Spain)
Source: International Congress 2022 – Clinical problems in respiratory medicine: 2
Session: Clinical problems in respiratory medicine: 2
Session type: Thematic Poster
Number: 2366
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Satué-Gracia (tarragona, Spain), c. de diego cabanes (tarragona, Spain), A. Vila-Rovira (Barcelona, Spain), C. Rodríguez-Casado (Barcelona, Spain), O. Ochoa-Gondar (Tarragona, Spain), A. Vila-Córcoles (Tarragona, Spain). Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination among adults with immunocompromising conditions.. 2366
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|